Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Traceless Materials has developed an innovative, fully biobased and home-compostable alternative to conventional plastics. Their material is derived from agricultural plant residues using a patent-pending process. It is certified plastic-free, can be processed with standard plastic technologies, and breaks down naturally within weeks under composting conditions. The company is scaling up production with its first large-scale facility opening in Hamburg-Harburg in 2024. No clinical results are relevant as the company does not operate in healthcare or drug development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Traceless Materials.